Immunotherapy of gliomas: a review.
D000328:Adult; D000818:Animals; D001375:Azaguanine / Q000627:therapeutic use; D001500:BCG Vaccine; D001921:Brain / Q000276:immunology; D001932:Brain Neoplasms / Q000150:complications / Q000276:immunology / Q000628:therapy*; D002648:Child; D004195:Disease Models, Animal; D005910:Glioma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000150:complications; D008130:Lomustine / Q000627:therapeutic use; D008213:Lymphocyte Activation; D051379:Mice; D008875:Middle Aged; D009374:Neoplasms, Experimental; D014373:Tuberculin
D001500:BCG Vaccine; D014373:Tuberculin; D008130:Lomustine; D001375:Azaguanine